Bausch Health Cos Operating Margin 2012-2025 | BHC
Current and historical operating margin for Bausch Health Cos (BHC) over the last 10 years. The current operating profit margin for Bausch Health Cos as of December 31, 2025 is 13.64%.
| Bausch Health Cos Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-12-31 | $10.27B | $1.81B | 17.66% |
| 2025-09-30 | $10.03B | $1.90B | 18.92% |
| 2025-06-30 | $9.86B | $1.60B | 16.19% |
| 2025-03-31 | $9.73B | $1.54B | 15.84% |
| 2024-12-31 | $9.63B | $1.55B | 16.06% |
| 2024-09-30 | $9.47B | $1.35B | 14.25% |
| 2024-06-30 | $9.20B | $1.05B | 11.37% |
| 2024-03-31 | $8.97B | $1.07B | 11.92% |
| 2023-12-31 | $8.76B | $0.96B | 11.00% |
| 2023-09-30 | $8.54B | $0.36B | 4.18% |
| 2023-06-30 | $8.35B | $0.59B | 7.03% |
| 2023-03-31 | $8.15B | $0.34B | 4.12% |
| 2022-12-31 | $8.12B | $0.45B | 5.59% |
| 2022-09-30 | $8.13B | $1.07B | 13.10% |
| 2022-06-30 | $8.19B | $1.40B | 17.03% |
| 2022-03-31 | $8.33B | $0.96B | 11.58% |
| 2021-12-31 | $8.43B | $0.45B | 5.34% |
| 2021-09-30 | $8.45B | $0.08B | 0.92% |
| 2021-06-30 | $8.48B | $-0.04B | -0.42% |
| 2021-03-31 | $8.04B | $0.21B | 2.57% |
| 2020-12-31 | $8.03B | $0.68B | 8.42% |
| 2020-09-30 | $8.04B | $-0.40B | -4.91% |
| 2020-06-30 | $8.11B | $-0.53B | -6.49% |
| 2020-03-31 | $8.60B | $-0.24B | -2.81% |
| 2019-12-31 | $8.60B | $-0.20B | -2.36% |
| 2019-09-30 | $8.50B | $0.90B | 10.57% |
| 2019-06-30 | $8.43B | $0.69B | 8.14% |
| 2019-03-31 | $8.40B | $0.18B | 2.19% |
| 2018-12-31 | $8.38B | $-2.38B | -28.45% |
| 2018-09-30 | $8.42B | $-2.73B | -32.43% |
| 2018-06-30 | $8.51B | $-2.81B | -33.04% |
| 2018-03-31 | $8.61B | $-2.39B | -27.76% |
| 2017-12-31 | $8.72B | $0.10B | 1.17% |
| 2017-09-30 | $8.96B | $0.57B | 6.40% |
| 2017-06-30 | $9.22B | $-0.33B | -3.55% |
| 2017-03-31 | $9.41B | $-0.42B | -4.47% |
| 2016-12-31 | $9.67B | $-0.57B | -5.85% |
| 2016-09-30 | $10.03B | $-0.55B | -5.47% |
| 2016-06-30 | $10.34B | $0.76B | 7.37% |
| 2016-03-31 | $10.65B | $1.02B | 9.61% |
| 2015-12-31 | $10.45B | $1.53B | 14.63% |
| 2015-09-30 | $9.91B | $1.97B | 19.83% |
| 2015-06-30 | $9.18B | $2.20B | 23.98% |
| 2015-03-31 | $8.49B | $2.22B | 26.09% |
| 2014-12-31 | $8.21B | $2.00B | 24.38% |
| 2014-09-30 | $8.05B | $1.62B | 20.13% |
| 2014-06-30 | $7.53B | $0.04B | 0.58% |
| 2014-03-31 | $6.59B | $-0.17B | -2.58% |
| 2013-12-31 | $5.77B | $-0.41B | -7.11% |
| 2013-09-30 | $4.63B | $-0.73B | -15.82% |
| 2013-06-30 | $3.97B | $0.19B | 4.76% |
| 2013-03-31 | $3.69B | $0.14B | 3.66% |
| 2012-12-31 | $3.48B | $0.08B | 2.27% |
| 2012-09-30 | $3.21B | $0.17B | 5.32% |
| 2012-06-30 | $2.93B | $0.25B | 8.67% |
| 2012-03-31 | $2.72B | $0.29B | 10.49% |
| 2011-12-31 | $2.43B | $0.30B | 12.32% |
| 2011-09-30 | $2.29B | $0.26B | 11.18% |
| 2011-06-30 | $1.90B | $0.02B | 0.95% |
| 2011-03-31 | $1.53B | $-0.05B | -3.34% |
| 2010-12-31 | $1.18B | $-0.11B | -9.31% |
| 2010-09-30 | $0.91B | $0.00B | -0.22% |
| 2010-06-30 | $0.91B | $0.18B | 19.93% |
| 2010-03-31 | $0.87B | $0.14B | 16.59% |
| 2009-12-31 | $0.82B | $0.18B | 22.17% |
| 2009-09-30 | $0.76B | $0.05B | 6.70% |
| 2009-06-30 | $0.73B | $0.05B | 7.00% |
| 2009-03-31 | $0.72B | $0.09B | 12.76% |
| 2008-12-31 | $0.76B | $0.10B | 13.36% |
| 2008-09-30 | $0.78B | $0.24B | 31.07% |
| 2008-06-30 | $0.79B | $0.25B | 31.26% |
| 2008-03-31 | $0.80B | $0.26B | 31.84% |
| 2007-12-31 | $0.84B | $0.29B | 34.64% |
| 2007-09-30 | $0.95B | $0.37B | 39.28% |
| 2007-06-30 | $1.05B | $0.45B | 42.84% |
| 2007-03-31 | $1.10B | $0.48B | 43.53% |
| 2006-12-31 | $1.07B | $0.46B | 42.63% |
| 2006-09-30 | $1.05B | $0.48B | 45.53% |
| 2006-06-30 | $1.02B | $0.47B | 45.88% |
| 2006-03-31 | $0.98B | $0.41B | 41.77% |
| 2005-12-31 | $0.94B | $0.35B | 37.74% |
| 2005-09-30 | $0.93B | $0.29B | 30.82% |
| 2005-06-30 | $0.89B | $0.22B | 24.83% |
| 2005-03-31 | $0.88B | $0.25B | 28.11% |
| 2004-12-31 | $0.89B | $0.27B | 29.88% |
| 2004-09-30 | $0.81B | $0.20B | 24.23% |
| 2004-06-30 | $0.81B | $0.18B | 22.77% |
| 2004-03-31 | $0.82B | $0.21B | 25.03% |
| 2003-12-31 | $0.82B | $0.21B | 26.00% |
| 2003-09-30 | $0.86B | $0.29B | 33.76% |
| 2003-06-30 | $0.86B | $0.33B | 38.55% |
| 2003-03-31 | $0.82B | $0.33B | 39.44% |
| 2002-12-31 | $0.79B | $0.33B | 42.26% |
| 2002-09-30 | $0.73B | $0.32B | 43.88% |
| 2002-06-30 | $0.67B | $0.30B | 44.18% |
| 2002-03-31 | $0.62B | $0.26B | 42.65% |
| 2001-12-31 | $0.58B | $0.25B | 43.05% |
| 2001-09-30 | $0.51B | $0.18B | 35.84% |
| 2001-06-30 | $0.44B | $0.15B | 34.62% |
| 2001-03-31 | $0.37B | $0.13B | 35.33% |
| 2000-12-31 | $0.30B | $0.10B | 33.78% |
| 2000-09-30 | $0.26B | $0.10B | 39.31% |
| 2000-06-30 | $0.22B | $0.09B | 39.27% |
| 2000-03-31 | $0.20B | $0.08B | 41.54% |
| 1999-12-31 | $0.18B | $0.08B | 44.89% |
| 1999-09-30 | $0.15B | $0.07B | 44.90% |
| 1999-06-30 | $0.13B | $0.06B | 45.38% |
| 1999-03-31 | $0.12B | $0.05B | 44.54% |
| 1998-12-31 | $0.11B | $0.05B | 43.36% |
| 1998-09-30 | $0.10B | $0.06B | 56.86% |
| 1998-06-30 | $0.09B | $0.07B | 69.15% |
| 1998-03-31 | $0.09B | $0.06B | 72.41% |
| 1997-12-31 | $0.08B | $0.06B | 75.31% |
| 1997-09-30 | $0.07B | $0.05B | 68.12% |
| 1997-06-30 | $0.07B | $0.03B | 48.48% |
| 1997-03-31 | $0.07B | $0.03B | 45.45% |
| 1996-12-31 | $0.07B | $0.04B | 58.21% |
| 1996-09-30 | $0.06B | $0.04B | 58.06% |
| 1996-06-30 | $0.05B | $0.03B | 70.21% |
| 1996-03-31 | $0.03B | $0.03B | 93.75% |
| 1995-12-31 | $0.02B | $0.02B | 100.00% |
| 1995-09-30 | $0.02B | $0.02B | 100.00% |
| 1995-06-30 | $0.02B | $0.02B | 100.00% |
| 1995-03-31 | $0.02B | $0.02B | 80.95% |
| 1994-12-31 | $0.02B | $0.01B | 76.47% |
| 1994-06-30 | $0.01B | $0.00B | 33.33% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $2.086B | $10.266B |
| Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $35.437B | 10.97 |
| BridgeBio Pharma (BBIO) | United States | $14.460B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $11.109B | 17.29 |
| Aspen Pharmacare (APNHY) | South Africa | $3.708B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.918B | 22.33 |
| Taysha Gene Therapies (TSHA) | United States | $1.290B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $0.924B | 7.28 |
| Personalis (PSNL) | United States | $0.630B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.451B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.210B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.052B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |